These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33826786)

  • 21. Intradermal Injection in Balding Region Versus Intramuscular Injection in Surrounding Muscles: A Split-Scalp, Randomized Trial on BoNT for Androgenetic Alopecia.
    Li J; Zhang S; Zhao W; Yang F; Liu M; Li X; Jiang X
    Dermatol Ther (Heidelb); 2024 Jun; 14(6):1671-1682. PubMed ID: 38824483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.
    Wessagowit V; Tangjaturonrusamee C; Kootiratrakarn T; Bunnag T; Pimonrat T; Muangdang N; Pichai P
    Australas J Dermatol; 2016 Aug; 57(3):e76-82. PubMed ID: 26010505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of platelet-rich plasma on female androgenetic alopecia: A randomized controlled trial.
    Dubin DP; Lin MJ; Leight HM; Farberg AS; Torbeck RL; Burton WB; Khorasani H
    J Am Acad Dermatol; 2020 Nov; 83(5):1294-1297. PubMed ID: 32649961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
    Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
    J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia.
    Li P; Sun Y; Nie L; Shavandi A; Yunusov KE; Hua Y; Jiang G
    Int J Biol Macromol; 2023 Sep; 249():126013. PubMed ID: 37517761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the efficacy of carboxytherapy in alopecia.
    Doghaim NN; El-Tatawy RA; Neinaa YME; Abd El-Samd MM
    J Cosmet Dermatol; 2018 Dec; 17(6):1275-1285. PubMed ID: 29460509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results of the use of scalp microneedling in different types of alopecia.
    Starace M; Alessandrini A; Brandi N; Piraccini BM
    J Cosmet Dermatol; 2020 Mar; 19(3):646-650. PubMed ID: 31254437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
    Zimber MP; Ziering C; Zeigler F; Hubka M; Mansbridge JN; Baumgartner M; Hubka K; Kellar R; Perez-Meza D; Sadick N; Naughton GK
    J Drugs Dermatol; 2011 Nov; 10(11):1308-12. PubMed ID: 22052313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study.
    Sudeep HV; Rashmi S; Jestin TV; Richards A; Gouthamchandra K; Shyamprasad K
    Clin Cosmet Investig Dermatol; 2023; 16():3251-3266. PubMed ID: 38021422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial.
    Suchonwanit P; Chalermroj N; Khunkhet S
    Lasers Med Sci; 2019 Aug; 34(6):1107-1114. PubMed ID: 30569416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
    Fields JR; Vonu PM; Monir RL; Schoch JJ
    Dermatol Ther; 2020 Jan; 33(1):e13202. PubMed ID: 31858672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical application of the Wnt/β-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia.
    Tosti A; Zaiac MN; Canazza A; Sanchis-Gomar F; Pareja-Galeano H; Alis R; Lucia A; Emanuele E
    J Cosmet Dermatol; 2016 Dec; 15(4):469-474. PubMed ID: 27121450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, prospective, vehicle-controlled double-blind study in men.
    Welzel J; Wolff HH; Gehring W
    J Cosmet Dermatol; 2022 Mar; 21(3):1057-1064. PubMed ID: 33955628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.